Skip to content
Mesa Laboratories logo

Mesa Laboratories

MLAB

Mesa Laboratories is a global life sciences tools provider that designs and manufactures critical quality control solutions for highly regulated industries.

Market cap
$527.02M+6.1%
Revenue$249.1M+3.4%
Free cash flow$39.6M-7.0%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 10, 2026 (In 4 weeks)
Revenue estimate$60.9M
EPS estimate$2.63

Financials

Q4 2026

Income statement

See full
Revenue$63.7M+2.6%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation & ratios

Valuation

See full
Market cap$527.02M+6.1%
Enterprise value$578.8M-11.3%
P/S2.1×0.0×

Profitability

See full
FCF margin15.9%-1.8pp

Returns & leverage

See full
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Segments

By geography

See full
US$30.1M-3.7%
Other$29.6M+14.3%
CN$4.1M-19.5%

By segment

See full
Clinical Genomics$12.2M+5.8%
Biopharmaceutical Development$8.8M-29.9%

Competitors

Profile

Mesa Laboratories is a global life sciences tools provider that designs and manufactures critical quality control solutions for highly regulated industries. The company focuses on ensuring product integrity and safety within the pharmaceutical, healthcare, and medical device sectors through a mix of consumable products and specialized services. Its value proposition is centered on the 'Mesa Way,' a lean-based operating system aimed at continuous improvement and protecting vulnerable populations.

Competitive position

Mesa holds a leading position in niche quality control markets, particularly in sterilization indicators and specialized metrology, competing on technical precision and regulatory compliance.

GeographiesNorth America, Europe, Asia Pacific
Customer segmentsPharmaceutical companies, Healthcare providers, Research laboratories, Medical device OEMs
Business modelManufacturing, Consumables-heavy razor-and-blade, Professional Services, Subscription SaaS
SuppliersRaw material suppliers, Electronic component manufacturers, Specialized chemical suppliers, Microorganism spore providers
CustomersBiopharmaceutical R&D teams, Hospital sterilization departments, Clinical pathology labs, Dialysis technicians
Listed1984
Employees736.0
CEOGary Owens
FilingsSEC EDGAR

Questions, answered.

What is Mesa Laboratories's market cap?
Mesa Laboratories (MLAB) has a market capitalization of $527.0M and trades on NASDAQ.
What is Mesa Laboratories's revenue and profitability?
Mesa Laboratories generated $249.1M in trailing twelve-month revenue, representing a net margin of 1.5%. Gross margin stands at 56.8%, with free cash flow of $39.6M. These figures are based on the Q1 2026 filing.
Who are Mesa Laboratories's competitors?
Mesa Laboratories's key competitors include Danaher Corporation, Steris PLC, Thermo Fisher Scientific, and others. These companies compete in similar markets and product categories.
What subsidiaries does Mesa Laboratories have?
Mesa Laboratories's subsidiaries include GKE GmbH, SAL GmbH, Beijing GKE Science & Technology Co. Ltd..
Where is Mesa Laboratories headquartered?
Mesa Laboratories is headquartered in United States of America and employs approximately 736 people. It has been publicly traded since 1984.